SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

CNTB

Connect Biopharma Holdings Ltd.
NASDAQHealth Care

Latest close: 0.91 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Sep 30, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Sep 15, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  3. Aug 12, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record17618 flagged findings
Reported transactions (Form 4)8since Mar 31, 2026 · and 38 other holdings
Corporate events (8-K)5since Jul 21, 2025

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-05-15capital return (buybacks/dividends)recentOpen filing ↗
    “…Calls on Shares and Forfeiture of Shares Our Board of Directors may from time to time make calls upon shareholders for any amounts…”
    +1 more passage from the same document
    • “…that have been called upon and remain unpaid are subject to forfeiture. Redemption, Repurchase and Surrender of Shares We may issue…”
  • 2026-03-31listing compliance noticerecentOpen filing ↗
    “…continued listing requirements of Nasdaq, it could result in a delisting of our ordinary shares. 77 TABLE OF CONTENTS Our ordinary…”
    +1 more passage from the same document
    • “…we must meet minimum financial and other requirements, including requirements for a minimum closing bid price per share of $1.00…”
  • 2026-03-31export control restrictionsrecentOpen filing ↗
    “…have a material and adverse impact on the stock performance of PRC-based issuers listed in the U.S. It is unclear if this proposed…”
    +1 more passage from the same document
    • “…PRC, U.S. or other laws and regulations on import and export controls, including the U.S. Department of Commerce’s Export…”
  • 2026-03-31capital return (buybacks/dividends)recentOpen filing ↗
    “…authorities in the PRC which we previously entered into. We have terminated the plan to build the facilities for which we had…”
  • 2026-03-31Department of Justice inquiryrecentOpen filing ↗
    “…under the DPF. The UK Extension to the DPF followed in October 2023, as an effective UK GDPR data transfer mechanism to U.S.…”
  • 2026-03-31health plan compliance riskrecentOpen filing ↗
    “…is otherwise false or fraudulent in any way; (2) arranging for or contracting with an individual or entity that is excluded from…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 176)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 6, 26SCHEDULE 13G ↗Passive stake · Braden M Leonard · 6.8% · event on Sep 30, 26
  • Insider transaction · 2 Form 4 filingsshow all 2hide
  • Sep 30, 268-K ↗Current report · Communication to the market · Other events
  • Sep 15, 268-K ↗Current report · Communication to the market · Other events
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Wei Zheng · 4.0% · event on Jun 30, 26 · amendment
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Ikarian Capital, LLC · 6.9% · event on Jun 30, 26 · amendment
  • Aug 12, 2610-Q ↗Quarterly report
  • Aug 12, 268-K ↗Current report · Results
  • Insider transaction · 3 Form 4 filingsshow all 3hide
  • May 28, 26CORRESP ↗Correspondence with the SEC
  • May 22, 26UPLOAD ↗Correspondence with the SEC
  • May 15, 26SCHEDULE 13G/A ↗Passive stake · Wei Zheng · 6.2% · event on Mar 31, 26 · amendment
  • May 15, 26F-3 ↗Securities offering
  • May 12, 2610-Q ↗Quarterly report
  • May 12, 268-K ↗Current report · Results
  • Apr 23, 268-K ↗Current report · Communication to the market · Other events
  • Apr 14, 26SCHEDULE 13G ↗Passive stake · Wubin Pan · 9.6%
  • Insider transaction · 2 Form 4 filingsshow all 2hide
  • Apr 1, 26SCHEDULE 13D/A ↗Stake with intent to influence · Panacea Innovation Limited · 21.2% · event on Mar 31, 26 · amendment
  • Apr 1, 26Form 4 ↗Insider transaction
  • Mar 31, 2610-K ↗Annual report

176 filings on record, the oldest from Jan 13, 21.

Listing the 25 most recent filings of the 176 on record.

8-Ks, explained

Structure3Governance2
  • Mar 30, 26StructureEntered a material agreement+4 more in the same filing8-K 1.01 ↗
  • Dec 23, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Jul 22, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Jul 21, 25StructureA material agreement was terminated+1 more in the same filing8-K 1.02 ↗

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • Panacea Innovation Limited21.2%Mar 31, 26SCHEDULE 13D/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Wubin Pan9.6%Apr 14, 26SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Zheng Wei9.0%Dec 31, 25SCHEDULE 13G/A ↗
  • Ikarian Capital, LLC6.9%Jun 30, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Braden M Leonard6.8%Sep 30, 26SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
  • Wei Zheng4.0%Jun 30, 26SCHEDULE 13G/A ↗2 earlier filings

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • May 29, 26Buy$372KJames Huang↗
  • Mar 31, 26Buy$4.0MJames Huang↗
Stock compensation, tax and giftsshow the 6 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Sep 30, 26Compensationamount n/aJEAN I LIU↗
  • Sep 30, 26Compensationamount n/aKleanthis Gabriel Xanthopoulos↗
  • Jun 30, 26Compensationamount n/aJEAN I LIU↗
  • Jun 30, 26Compensationamount n/aKleanthis Gabriel Xanthopoulos↗
  • Mar 31, 26Compensationamount n/aJEAN I LIU↗
  • Mar 31, 26Compensationamount n/aKleanthis Gabriel Xanthopoulos↗

The full record holds 8 transactions and goes back to Mar 16, 26.

Its sector and its market

Connect Biopharma Holdings Ltd. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Connect Biopharma Holdings Ltd., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Connect Biopharma Holdings Ltd. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
176 documents on file, from Jan 13, 2021 to Oct 6, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.